Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )

Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China' s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market.

Kalorama' s Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a solid look at opportunities available for pharmaceutical companies in these emerging markets, including the following information:

• Competitive Activity
• Current Market Size
• Forecast to 2012
• Population, Economy and Demographics
• Health Indicators for each Country
• Market Trends
• Company Profiles

What economic and demographic factors are driving companies to this market? Who are the major players having success in this area? What should companies know about each country' s healthcare system in order to plan their strategy. For each country, this report answers these questions and analyzes markets a look at the following specific segments

• Cardiovascular Drugs
• Gastrointestinal Drugs
• Infection control Drugs
• Neurotherapeutics/CNS Drugs
• Oncology Drugs
• Respiratory Drugs
• Others

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel.

These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.